Hadasit Medical Research Services & Development Ltd.

https://www.hadasit.co.il

Hadasit is the commercial arm and technology transfer company of Hadassah University Hospitals (Hadassah). Hadasit has the exclusive rights to the innovations and inventions emerging from Hadassah and is fully dedicated to exploiting their potential. Hadasit also promotes and commercializes Hadassah's accumulated knowledge and expertise in treatment, research and innovation across all its medical specialities for the benefit of public health. Hadasit collaborates with many of the world's leading pharmaceutical companies, internationally renowned research institutions such as Harvard Medical School, as well as investment firms, biotech companies and other commercial entities. Hadasit's portfolio includes about 170 active patent families which have already delivered medical and commercial breakthroughs, a prominent example being the cancer treatment liposomal-doxorubicin, which was developed together with the Hebrew University. *

	Start	1986-01-01 established (approx)
	Industry	healthcare

	Street	Hadussah Ein Kerem Jerusalem BioPark
	City	91120 Jerusalem
	Tel	+972-2-6778757
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«:

		Record changed: 2018-05-21

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)